Bing

Cellceutix Corp (OTCMKTS:CTIX) may have closed with a gain of 6.67% at the end of the last trading session but the structure of the daily candle was anything but encouraging for the bulls. The stock had opened with a …
Stocks and Trades News and Media · 8/21/2015
The press release read: Cellceutix Reports Spleen Lesion 'Disappears' in Patient With Metastatic Stage 4 Ovarian Cancer in Clinical Trial of Anti-Cancer Drug Kevetrin CTIX stock went up nearly 25% that day as traders and investors were enamored with the ...
Seeking Alpha · 1/23/2015
Cellceutix last week learned that the application remains pending due to the price of CTIX stock currently below the minimum requirement. Cellceutix wishes to reiterate its stance that it will not perform a reverse split to meet the higher share price ...
Yahoo Finance · 6/8/2015
More from Bing News
So when we came across what appears to be a very heavily discussed OTC stock called Cellceutix, we had to take a closer look. Founded in 2007, Cellceutix (CTIX) is working to develop a number of pharmaceutical compounds to treat cancer. Their lead …
nanalyze.com · 7/20/2015
The stock was essentially not trading ... As far as self-enrichment with CTIX, long-term shareholders know myself and Dr. Menon deferred our salaries for many years. We were working very hard to build the company without receiving a paycheck.
Financial Content · 8/10/2015
company
Stock symbols are the cornerstone of the stock market and a pure source of identity for companies. Billions of investment dollars change hands every day based on those little letters. Among traders of smaller-cap stocks, the companies are often better ...
Value Walk · BySydra Farooqui · 5/1/2012
It's tough to bet against the crowd, especially when it looks like a stock's momentum is still intact. Trust me though...TeleCommunication Systems, Inc. (NASDAQ:TSYS), Cellceutix Corp. (OTC:CTIX), and Amarantus Biosciences Inc. (OTC:AMBS) have all …
Smallcap Network · ByJames E. Brumley · 12/27/2012
BEVERLY, MA--(Marketwired - August 11, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical ... including the amount and timing of the sale of shares of common stock to Aspire Capital; the fact that Cellceutix's ...
Stockhouse · 8/11/2015
Rare Cancer
BEVERLY, MA--(Marketwired - August 10, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical ... The current liabilities were $2,898,691 with expenses mounting daily. The stock was essentially not trading.
marketwired.com · 8/10/2015
BEVERLY, MA -- (Marketwired) -- 08/03/15 -- Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical ... including the amount and timing of the sale of shares of common stock to Aspire Capital; the fact that Cellceutix's ...
StreetInsider · 8/3/2015